Cargando…

Exopolysaccharides of Lactobacillus rhamnosus GG ameliorate Salmonella typhimurium-induced intestinal inflammation via the TLR4/NF-κB/MAPK pathway

BACKGROUND: Salmonella typhimurium (S.T), as an important foodborne bacterial pathogen, can cause diarrhea and gastroenteritis in humans and animals. Numerous studies have confirmed that exopolysaccharides (EPSs) have various biological functions, but the mechanism through which EPSs improve the imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jinze, Li, Qiuke, Wu, Qianhui, Gao, Nan, Wang, Zhihua, Yang, Yang, Shan, Anshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987055/
https://www.ncbi.nlm.nih.gov/pubmed/36872332
http://dx.doi.org/10.1186/s40104-023-00830-7
_version_ 1784901297383669760
author Li, Jinze
Li, Qiuke
Wu, Qianhui
Gao, Nan
Wang, Zhihua
Yang, Yang
Shan, Anshan
author_facet Li, Jinze
Li, Qiuke
Wu, Qianhui
Gao, Nan
Wang, Zhihua
Yang, Yang
Shan, Anshan
author_sort Li, Jinze
collection PubMed
description BACKGROUND: Salmonella typhimurium (S.T), as an important foodborne bacterial pathogen, can cause diarrhea and gastroenteritis in humans and animals. Numerous studies have confirmed that exopolysaccharides (EPSs) have various biological functions, but the mechanism through which EPSs improve the immunity of animals against the invasion of pathogenic bacteria is unclear. Here, we explored the protective effect of EPSs of Lactobacillus rhamnosus GG (LGG) on the S.T-infected intestine. METHODS: Mice received adequate food and drinking water for one week before the start of the experiment. After 7 d of prefeeding, 2×10(8) CFU/mL S.T solution and an equivalent volume of saline (control group) were given orally for 1 d. On the fourth day, the mice were treated with 0.5 mg/mL EPSs, 1.0 mg/mL EPSs, 2.0 mg/mL EPSs, or 2.0 mg/mL penicillin for 7 d. Finally, the body and relative organ weight, histological staining, and the levels of antioxidant enzyme activity and inflammatory cytokines were determined. RESULTS: The S.T-infected mice exhibited symptoms of decreased appetite, somnolence, diarrhea and flagging spirit. Treatment with EPSs and penicillin improved the weight loss of the mice, and the high dose of EPSs showed the best therapeutic effect. EPSs significantly ameliorated S.T-induced ileal injury in mice. High-dose EPSs were more effective than penicillin for alleviating ileal oxidative damage induced by S.T. The mRNA levels of inflammatory cytokines in the ileum of mice showed that the regulatory effects of EPSs on inflammatory cytokines were better than those of penicillin. EPSs could inhibit the expression and activation of key proteins of the TLR4/NF-κB/MAPK pathway and thereby suppress the level of S.T-induced ileal inflammation. CONCLUSIONS: EPSs attenuate S.T-induced immune responses by inhibiting the expression of key proteins in the TLR4/NF-κB/MAPK signaling pathway. Moreover, EPSs could promote bacterial aggregation into clusters, which may be a potential strategy for reducing the bacterial invasion of intestinal epithelial cells.
format Online
Article
Text
id pubmed-9987055
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99870552023-03-07 Exopolysaccharides of Lactobacillus rhamnosus GG ameliorate Salmonella typhimurium-induced intestinal inflammation via the TLR4/NF-κB/MAPK pathway Li, Jinze Li, Qiuke Wu, Qianhui Gao, Nan Wang, Zhihua Yang, Yang Shan, Anshan J Anim Sci Biotechnol Research BACKGROUND: Salmonella typhimurium (S.T), as an important foodborne bacterial pathogen, can cause diarrhea and gastroenteritis in humans and animals. Numerous studies have confirmed that exopolysaccharides (EPSs) have various biological functions, but the mechanism through which EPSs improve the immunity of animals against the invasion of pathogenic bacteria is unclear. Here, we explored the protective effect of EPSs of Lactobacillus rhamnosus GG (LGG) on the S.T-infected intestine. METHODS: Mice received adequate food and drinking water for one week before the start of the experiment. After 7 d of prefeeding, 2×10(8) CFU/mL S.T solution and an equivalent volume of saline (control group) were given orally for 1 d. On the fourth day, the mice were treated with 0.5 mg/mL EPSs, 1.0 mg/mL EPSs, 2.0 mg/mL EPSs, or 2.0 mg/mL penicillin for 7 d. Finally, the body and relative organ weight, histological staining, and the levels of antioxidant enzyme activity and inflammatory cytokines were determined. RESULTS: The S.T-infected mice exhibited symptoms of decreased appetite, somnolence, diarrhea and flagging spirit. Treatment with EPSs and penicillin improved the weight loss of the mice, and the high dose of EPSs showed the best therapeutic effect. EPSs significantly ameliorated S.T-induced ileal injury in mice. High-dose EPSs were more effective than penicillin for alleviating ileal oxidative damage induced by S.T. The mRNA levels of inflammatory cytokines in the ileum of mice showed that the regulatory effects of EPSs on inflammatory cytokines were better than those of penicillin. EPSs could inhibit the expression and activation of key proteins of the TLR4/NF-κB/MAPK pathway and thereby suppress the level of S.T-induced ileal inflammation. CONCLUSIONS: EPSs attenuate S.T-induced immune responses by inhibiting the expression of key proteins in the TLR4/NF-κB/MAPK signaling pathway. Moreover, EPSs could promote bacterial aggregation into clusters, which may be a potential strategy for reducing the bacterial invasion of intestinal epithelial cells. BioMed Central 2023-03-06 /pmc/articles/PMC9987055/ /pubmed/36872332 http://dx.doi.org/10.1186/s40104-023-00830-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Jinze
Li, Qiuke
Wu, Qianhui
Gao, Nan
Wang, Zhihua
Yang, Yang
Shan, Anshan
Exopolysaccharides of Lactobacillus rhamnosus GG ameliorate Salmonella typhimurium-induced intestinal inflammation via the TLR4/NF-κB/MAPK pathway
title Exopolysaccharides of Lactobacillus rhamnosus GG ameliorate Salmonella typhimurium-induced intestinal inflammation via the TLR4/NF-κB/MAPK pathway
title_full Exopolysaccharides of Lactobacillus rhamnosus GG ameliorate Salmonella typhimurium-induced intestinal inflammation via the TLR4/NF-κB/MAPK pathway
title_fullStr Exopolysaccharides of Lactobacillus rhamnosus GG ameliorate Salmonella typhimurium-induced intestinal inflammation via the TLR4/NF-κB/MAPK pathway
title_full_unstemmed Exopolysaccharides of Lactobacillus rhamnosus GG ameliorate Salmonella typhimurium-induced intestinal inflammation via the TLR4/NF-κB/MAPK pathway
title_short Exopolysaccharides of Lactobacillus rhamnosus GG ameliorate Salmonella typhimurium-induced intestinal inflammation via the TLR4/NF-κB/MAPK pathway
title_sort exopolysaccharides of lactobacillus rhamnosus gg ameliorate salmonella typhimurium-induced intestinal inflammation via the tlr4/nf-κb/mapk pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987055/
https://www.ncbi.nlm.nih.gov/pubmed/36872332
http://dx.doi.org/10.1186/s40104-023-00830-7
work_keys_str_mv AT lijinze exopolysaccharidesoflactobacillusrhamnosusggamelioratesalmonellatyphimuriuminducedintestinalinflammationviathetlr4nfkbmapkpathway
AT liqiuke exopolysaccharidesoflactobacillusrhamnosusggamelioratesalmonellatyphimuriuminducedintestinalinflammationviathetlr4nfkbmapkpathway
AT wuqianhui exopolysaccharidesoflactobacillusrhamnosusggamelioratesalmonellatyphimuriuminducedintestinalinflammationviathetlr4nfkbmapkpathway
AT gaonan exopolysaccharidesoflactobacillusrhamnosusggamelioratesalmonellatyphimuriuminducedintestinalinflammationviathetlr4nfkbmapkpathway
AT wangzhihua exopolysaccharidesoflactobacillusrhamnosusggamelioratesalmonellatyphimuriuminducedintestinalinflammationviathetlr4nfkbmapkpathway
AT yangyang exopolysaccharidesoflactobacillusrhamnosusggamelioratesalmonellatyphimuriuminducedintestinalinflammationviathetlr4nfkbmapkpathway
AT shananshan exopolysaccharidesoflactobacillusrhamnosusggamelioratesalmonellatyphimuriuminducedintestinalinflammationviathetlr4nfkbmapkpathway